News

 

 

Nexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02) and Presentation at the Veterinary Pain Short Course Conference

DUBLIN, Ireland, July 20, 2016 (GLOBE NEWSWIRE) --Link here.

Read more about Nexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02) and Presentation at the Veterinary Pain Short Course Conference

SeaDragon appoints new Chief Executive

NZX / MEDIA RELEASE 18 July 2016. Link here.

Read more about SeaDragon appoints new Chief Executive

Avita Medical announces Rights Issue raises $9 million

Northridge, CA, Perth, Australia and London, United Kingdom – 11 July 2016

Read more about Avita Medical announces Rights Issue raises $9 million

Avita Medical scoops One Nucleus Summer BioNewsRound Award 2016t

Northridge, CA, Perth, Australia and London, United Kingdom – 29 June 2016

Read more about Avita Medical scoops One Nucleus Summer BioNewsRound Award 2016t

Avita Medical Awarded US$7.96m in BARDA Extension Deal

Northridge, CA, Perth, Australia and London, United Kingdom – 27 June 2016

Read more about Avita Medical Awarded US$7.96m in BARDA Extension Deal

Avita Medical Appoints COO and VP of Sales and Marketing

Link here.

Read more about Avita Medical Appoints COO and VP of Sales and Marketing

Avita Medical’s Regenerative Skin Technology significantly reduces burn scars and healing time

Northridge, CA, Perth, Australia and London, United Kingdom – 2 September 2016

Read more about Avita Medical’s Regenerative Skin Technology significantly reduces burn scars and healing time

Nexvet Presents Expanded Positive Clinical Data for Ranevetmab (NV-01) and Frunevetmab (NV-02) at ACVIM

DUBLIN, Ireland, June 09, 2016 (GLOBE NEWSWIRE)- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, is today presenting expanded results regarding completed clinical studies for ranevetmab (or “NV-01”) and frunevetmab...

Read more about Nexvet Presents Expanded Positive Clinical Data for Ranevetmab (NV-01) and Frunevetmab (NV-02) at ACVIM

Nexvet Announces Opening of Manufacturing Facility and Production Milestone Achievement

DUBLIN, Ireland, June 03, 2016 (GLOBE NEWSWIRE) - Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics developer, today announced the official opening of BioNua Limited, its veterinary biologics manufacturing facility in...

Read more about Nexvet Announces Opening of Manufacturing Facility and Production Milestone Achievement

Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016

DUBLIN, Ireland, May 12, 2016 (GLOBE NEWSWIRE) -- Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced its financial results for the three and nine-month periods ended March 31, 2016.

Read more about Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016

1 ... 3 4 5 6 7 ... 22